2009
DOI: 10.1111/j.1365-2249.2009.03966.x
|View full text |Cite
|
Sign up to set email alerts
|

Cells with regulatory function of the innate and adaptive immune system in primary Sjögren’s syndrome

Abstract: SummaryThe aim of the present study was to describe subsets of cells with regulatory properties in primary Sjögren's syndrome (pSS) ,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
47
0
2

Year Published

2010
2010
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 75 publications
(54 citation statements)
references
References 33 publications
5
47
0
2
Order By: Relevance
“…1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 The role of regulatory T cells in systemic autoimmune diseases and UCTD In line with this hypothesis, previous studies conducted on patients with systemic autoimmune and rheumatic disease described that the selective decrease in the number of Tregs or, alternatively, a diminished suppressor function of Tregs are characteristic to these diseases (e.g. SLE, MCTD, Sjögren's syndrome or RA [13][14][15][16][17]. These data indicate that in patients with established autoimmune conditions a well-characterized quantitative and/or qualitative impairment of the regulatory T-cell pool exists.…”
supporting
confidence: 52%
“…1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 The role of regulatory T cells in systemic autoimmune diseases and UCTD In line with this hypothesis, previous studies conducted on patients with systemic autoimmune and rheumatic disease described that the selective decrease in the number of Tregs or, alternatively, a diminished suppressor function of Tregs are characteristic to these diseases (e.g. SLE, MCTD, Sjögren's syndrome or RA [13][14][15][16][17]. These data indicate that in patients with established autoimmune conditions a well-characterized quantitative and/or qualitative impairment of the regulatory T-cell pool exists.…”
supporting
confidence: 52%
“…For phenotypic analysis from heparinized blood samples we used CD3-fluorescein isothiocyanate (FITC), CD4-FITC, CD8-R-phycoerythrin (PE), CD19-R-phycoerythrinCyanine dye 5 (PE-Cy5), and CD16+CD56-PE (BD Biosciences, San Diego, CA, USA and For the identification of CD4 + T helper cell subsets we used intracytoplasmic cytokine staining method which has been described previously [25,26]. …”
Section: Determination Of Lymphocyte Subpopulationsmentioning
confidence: 99%
“…The decreased IL-10-producing B reg cell percentages in pSS may elucidate our previous observations that, despite the increased peripheral IL-10-producing regulatory T (Tr1) cell proportions, a significant decrease in soluble IL-10 levels can be detected in the disease. We assume that, along with the decrease in IL-10 production of B reg cells, the intensification of a counterbalance mechanism appears; thus, levels of IL-10-producing Tr1 cells increase as a feedback process attempting to compensate the progression of disproportional immune responses [42].…”
Section: Cd27mentioning
confidence: 99%